PCSA
Processa Pharmaceuticals Inc

3,838
Loading...
Loading...
News
all
press releases
Analysts Are Bullish on Top Healthcare Stocks: Processa Pharmaceuticals (PCSA), Healthequity (HQY)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Processa Pharmaceuticals (PCSA Research Report), Healthequity...
TipRanks Financial Blog·1y ago
News Placeholder
More News
News Placeholder
Processa Pharmaceuticals' Future in Jeopardy: A Dive into Its Financial Crisis and Industry Risks
Processa Pharmaceuticals, Inc. (PCSA) has disclosed a new risk, in the Accounting & Financial Operations category. Processa Pharmaceuticals, Inc. c...
TipRanks Financial Blog·1y ago
News Placeholder
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Globe Newswire·1y ago
News Placeholder
12 titoli sanitari in movimento, after-market del 27/03/2024
Titoli in rialzo Le azioni di Avalo Therapeutics (NASDAQ:AVTX) hanno guadagnato il 267,15% a 17,44 dollari durante la sessione after-market di mercoled . Le azioni di Processa Pharma (NASDAQ:PCSA...
Benzinga·1y ago
News Placeholder
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Globe Newswire·1y ago
News Placeholder
Processa Pharmaceuticals (NASDAQ:PCSA) Stock Rating Reaffirmed by Benchmark
Processa Pharmaceuticals (NASDAQ:PCSA Get Free Report)s stock had its speculative buy rating restated by Benchmark in a research note issued on Wednesday, Benzinga...
Ticker Report·2y ago
News Placeholder
Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Globe Newswire·2y ago
News Placeholder
Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference
HANOVER, MD, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Globe Newswire·2y ago
News Placeholder
Processa Pharmaceuticals regains compliance with Nasdaq minimum bid price rule
Processa Pharmaceuticals regains compliance with Nasdaq minimum bid price rule...
SeekingAlpha.com: All News·2y ago
News Placeholder
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Globe Newswire·2y ago

Latest PCSA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.